All articles by Robert Hutchens

Global drug companies are facing disruption. One powerful strategic response is to rethink their manufacturing and operations footprints.

Spending on prescription drugs is one of the biggest contributors to the unrelenting rise in the cost of health care for business. Critics of rising drug costs are quick to blame pharmaceutical companies’ advertising and aggressive sales practices for the problem. In fact, the real culprit is a third-party reimbursement system that undermines economic incentives to control costs.